The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, addressing mammography's limitations in dense breast tissue. The test achieved 92.3 ...
Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing high sensitivity and specificity, explains Justin Drake, PhD. Current standard ...
The National Institute for Research and Treatment (NICRAT) has strengthened the capacity of health workers in the South-West geopolitical zone of Nigeria through training on the application of ...
The digital health revolution is accelerating at an unprecedented pace, transforming how we diagnose diseases, deliver care, and manage wellness. From AI-powere ...
The Amazing Times on MSN

20 breakthroughs that happened in 2025

From scientific breakthroughs to global diplomacy, this year has produced numerous events that demonstrate humanity's resilience, creativity, and commitment to a better future. While every year brings ...
Gliomas are cancers that originate directly in the brain, instead of spreading to the brain from other parts of the body.
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...
Artificial intelligence tools in neuro-oncology demonstrate robust performance in detecting brain metastases and predicting clinical outcomes.
As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.
Researchers at Osaka Metropolitan University have discovered a practical way to detect and fix common labeling errors in ...